Solid Biosciences (SLDB) Reports Q1 Loss of $0.61/sh
Tweet
Share
E-mailGet Alerts SLDB Hot Sheet
Join SI Premium – FREE
Solid Biosciences (NASDAQ: SLDB) reported Q1 EPS of ($0.61), versus ($1.25) reported last year.
For earnings history and earnings-related data on Solid Biosciences (SLDB) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Raymond James Downgrades Phreesia Inc. (PHR) to Market Perform
- Freedom Capital Starts Terawulf Inc. (WULF) at Buy
- Novartis DM1 drug trial misses primary endpoint in Phase III study
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
